Cancer of unknown primary. Epidemiology and pathogenesis;CUP-Syndrom. Epidemiologie und Pathogenese

Radiologe

Volumn 54, Issue 2, 2014, Pages 107-111

  Loffler H ^a   Neben, K ^b   Kramer A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Klinikum Mittelbaden   (Germany)

Author keywords

Autopsy; Carcinoma; Gene expression profiling; Metastases; Primary tumor

Indexed keywords

ABDOMINAL TUMOR; ARTICLE; CANCER OF UNKNOWN PRIMARY SITE; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; PREVALENCE; RISK ASSESSMENT; SEX RATIO; SMOKING;

ABDOMINAL NEOPLASMS; CAUSALITY; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; NEOPLASMS, UNKNOWN PRIMARY; PREVALENCE; RISK ASSESSMENT; SEX DISTRIBUTION; SMOKING;

EID: 84898538297     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-013-2544-z     Document Type: Article

References (33)

1. Abbruzzese JL, Lenzi R, Raber MN et al (1993) The biology of unknown primary tumors. Semin Oncol 20:238-243
2. Altman E, Cadman E (1986) An analysis of 1539 patients with cancer of unknown primary site. Cancer 57:120-124
3. Anonymous. http://www.destatis.de
4. Bar-Eli M, Abbruzzese JL, Lee-Jackson D et al (1993) p53 gene mutation spectrum in human unknown primary tumors. Anticancer Res 13:1619-1623
5. Briasoulis E, Tsokos M, Fountzilas G et al (1998) Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A Hellenic Co-operative Oncology Group study. Anticancer Res 18:1907-1914
6. Califano J, Westra WH, Koch W et al (1999) Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. J Natl Cancer Inst 91:599-604
7. Culine S, Lortholary A, Voigt JJ et al (2003) Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study-trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01). J Clin Oncol 21:3479-3482
8. Dova L, Pentheroudakis G, Georgiou I et al (2007) Global profiling of EGFR gene mutation, amplification, regulation and tissue protein expression in unknown primary carcinomas: to target or not to target? Clin Exp Metastasis 24:79-86
9. Fabre E, Jira H, Izard V et al (2004) ,Burned-out' primary testicular cancer. BJU Int 94:74-78
10. Greco FA, Burris HA 3rd, Litchy S et al (2002) Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study. J Clin Oncol 20:1651-1656
11. Hainsworth JD, Rubin MS, Spigel DR et al (2013) Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon Research Institute. J Clin Oncol 31:217-223
12. Hedley DW, Leary JA, Kirsten F (1985) Metastatic adenocarcinoma of unknown primary site: abnormalities of cellular DNA content and survival. Eur J Cancer Clin Oncol 21:185-189
13. Horlings HM, Van Laar RK, Kerst JM et al (2008) Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary. J Clin Oncol 26:4435-4441
14. Huebner G, Link H, Kohne CH et al (2009) Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial. Br J Cancer 100:44-49
15. Kim KW, Krajewski KM, Jagannathan JP et al (2013) Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know. AJR Am J Roentgenol 200:484-492
16. Klein CA, Blankenstein TJ, Schmidt-Kittler O et al (2002) Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360:683-689
17. Länger F, Von Wasielewski R, Kreipe HH (2006) Bedeutung der Immunhistochemie für die Diagnose des Cholangiokarzinoms. Pathologe 27:244-250
18. Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396:643-649
19. Levi F, Te VC, Erler G et al (2002) Epidemiology of unknown primary tumours. Eur J Cancer 38:1810-1812
20. Massard C, Voigt JJ, Laplanche A et al (2007) Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy? Br J Cancer 97:857-861
21. Motzer RJ, Rodriguez E, Reuter VE et al (1995) Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. J Clin Oncol 13:274-282
22. Neben K, Hübner G, Folprecht G et al (2008) Metastases in the absence of a primary tumor: advances in the diagnosis and treatment of cup syndrome. Deutsch Arztebl Int 105:733-740
23. Offner S, Schmaus W, Witter K et al (1999) p53 gene mutations are not required for early dissemination of cancer cells. Proc Natl Acad Sci U S A 96:6942-6946
24. Palmeri S, Lorusso V, Palmeri L et al (2006) Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site: results of an Italian multicenter, randomized, phase II study. Cancer 107:2898-2905
25. Pantou D, Tsarouha H, Papadopoulou A et al (2003) Cytogenetic profile of unknown primary tumors: clues for their pathogenesis and clinical management. Neoplasia 5:23-31
26. Pentheroudakis G, Golfinopoulos V, Pavlidis N (2007) Switching benchmarks in cancer of unknown primary: from autopsy to microarray. Eur J Cancer 43:2026-2036
27. Petersen I, Hidalgo A, Petersen S et al (2000) Chromosomal imbalances in brain metastases of solid tumors. Brain Pathol 10:395-401
28. Ramaswamy S, Ross KN, Lander ES et al (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49-54
29. Rosenfeld N, Aharonov R, Meiri E et al (2008) MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26:462-469
30. Van De Wouw AJ, Janssen-Heijnen ML, Coebergh JW et al (2002) Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer 38:409-413
31. Varadhachary GR, Talantov D, Raber MN et al (2008) Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. J Clin Oncol 26:4442-4448
32. Wick MR, Goellner JR, Wolfe JT 3rd et al (1985) Adnexal carcinomas of the skin. I. Eccrine carcinomas. Cancer 56:1147-1162
33. Yuhas JM, Pazmino NH (1974) Inhibition of subcutaneously growing line 1 carcinomas due to metastatic spread. Cancer Res 34:2005-2010